While coronavirus disease 2019 (COVID-19) is predominantly self-limited, up to 20% of
symptomatic individuals will progress to severe or critical disease with clinical …

In the 2014 Ebola outbreak, close to 30 000 individuals developed Ebola viral disease
(EVD), and numerous therapies were tested against this virus, including chloroquine …

Everyone wants new treatments and vaccines to address the devastation of coronavirus
disease 2019 (COVID-19). But, currently, under intense pressure and based on hope and …

(WHO) CountryOfficeinChinareportednovel “viralpneumonias of unknown cause” in Wuhan,
but China did not confirm case clusters until January 3, 2020. Two years later, more than …

Since first reported in Wuhan, China, in late December 2019, the outbreak of the novel
coronavirus now known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) …

Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

As of July 30, 2020, more than 17 million people worldwide have been diagnosed with
coronavirus disease 2019 (COVID-19), and more than 665 000 have died. In many …

Coronavirus disease (COVID-19), which appeared in December 2019, presents a global
challenge, particularly in the rapid increase of critically ill patients with pneumonia and …

As the United States struggles with a prolonged wave of acute coronavirus disease 2019
(COVID-19; see article recently published in American Family Physician), family physicians …